| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.56e-12 | 26 | 117 | 8 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.77e-11 | 52 | 117 | 9 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B | 3.71e-10 | 171 | 117 | 12 | GO:0015081 |
| GeneOntologyMolecularFunction | sodium ion binding | 1.22e-08 | 14 | 117 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TMEM87A SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ATP2B1 KCNH5 | 9.22e-08 | 465 | 117 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.78e-07 | 26 | 117 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG1 ABCA4 SLC44A4 TMEM87A SVOPL SLC5A4 SLC6A8 SLC9A4 SIDT2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ABCG2 ABCC2 ATP2B1 KCNH5 | 1.20e-06 | 1180 | 117 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRG1 ABCA4 SLC44A4 TMEM87A SVOPL SLC5A4 SLC6A8 SLC9A4 SIDT2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO SCNN1B ABCG2 ABCC2 ATP2B1 KCNH5 | 1.40e-06 | 1289 | 117 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG1 TMEM87A SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ABCC2 ATP2B1 KCNH5 | 2.02e-06 | 758 | 117 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.22e-06 | 18 | 117 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TMEM87A SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ATP2B1 KCNH5 | 3.94e-06 | 627 | 117 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TMEM87A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 5.61e-06 | 343 | 117 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TMEM87A SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ATP2B1 KCNH5 | 7.85e-06 | 664 | 117 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R2 OR11G2 SIGMAR1 MCHR2 ADGRB2 ADGRB3 OR6C65 ADGRV1 ADGRL4 ADORA2A GPR161 HCAR3 CELSR1 TAS2R5 GPR158 MRGPRX1 TAS2R20 | 1.54e-05 | 884 | 117 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG1 TMEM87A SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ATP2B1 KCNH5 | 1.56e-05 | 793 | 117 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG1 TMEM87A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 1.63e-05 | 459 | 117 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.06e-05 | 28 | 117 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | channel activity | GABRG1 TMEM87A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 6.03e-05 | 525 | 117 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRG1 TMEM87A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 6.14e-05 | 526 | 117 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.37e-05 | 37 | 117 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | glucose-6-phosphatase activity | 1.02e-04 | 3 | 117 | 2 | GO:0004346 | |
| GeneOntologyMolecularFunction | sugar-terminal-phosphatase activity | 1.02e-04 | 3 | 117 | 2 | GO:0050309 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R2 GABRG1 LILRB3 OR11G2 SIGMAR1 MCHR2 ADGRB2 ADGRB3 OR6C65 ADGRV1 ADGRL4 ADORA2A GPR161 HCAR3 CELSR1 IGF2R TAS2R5 GPR158 MRGPRX1 TAS2R20 | 1.10e-04 | 1353 | 117 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.26e-04 | 17 | 117 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 5.03e-04 | 6 | 117 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.62e-04 | 70 | 117 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 9.31e-04 | 8 | 117 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.22e-03 | 36 | 117 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 1.49e-03 | 10 | 117 | 2 | GO:0050308 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.81e-03 | 11 | 117 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 1.81e-03 | 11 | 117 | 2 | GO:0019203 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.37e-03 | 230 | 117 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.80e-03 | 48 | 117 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.97e-03 | 49 | 117 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.97e-03 | 49 | 117 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.40e-03 | 15 | 117 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.45e-03 | 172 | 117 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.55e-03 | 334 | 117 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.88e-03 | 109 | 117 | 4 | GO:0042626 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.39e-11 | 36 | 118 | 8 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD | 2.10e-10 | 208 | 118 | 13 | GO:0035725 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.70e-09 | 87 | 118 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | membrane depolarization | ADORA2A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO | 1.89e-09 | 121 | 118 | 10 | GO:0051899 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.36e-09 | 62 | 118 | 8 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.69e-09 | 63 | 118 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD | 6.34e-09 | 275 | 118 | 13 | GO:0006814 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 4.86e-08 | 127 | 118 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 6.13e-08 | 93 | 118 | 8 | GO:0086003 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.41e-07 | 153 | 118 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.62e-07 | 112 | 118 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.06e-07 | 167 | 118 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 8.82e-07 | 57 | 118 | 6 | GO:0050974 | |
| GeneOntologyBiologicalProcess | action potential | 2.37e-06 | 201 | 118 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | muscle contraction | SLC6A8 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ATP2B1 | 3.22e-06 | 400 | 118 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | metal ion transport | SPG11 SLC5A4 ADORA2A SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 3.89e-06 | 1000 | 118 | 19 | GO:0030001 |
| GeneOntologyBiologicalProcess | circulatory system process | ADORA2A NAMPT SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B ABCG2 DMD ABCC2 EMP2 ATP2B1 | 4.38e-06 | 733 | 118 | 16 | GO:0003013 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.44e-06 | 217 | 118 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 4.50e-06 | 75 | 118 | 6 | GO:0050982 | |
| GeneOntologyBiologicalProcess | heart contraction | 8.40e-06 | 298 | 118 | 10 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.15e-05 | 309 | 118 | 10 | GO:0003015 | |
| GeneOntologyBiologicalProcess | muscle system process | SLC6A8 FDPS SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ATP2B1 | 1.53e-05 | 547 | 118 | 13 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRG1 ADORA2A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO DMD KCNH5 | 1.92e-05 | 559 | 118 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | blood circulation | ADORA2A NAMPT SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD EMP2 ATP2B1 | 2.04e-05 | 648 | 118 | 14 | GO:0008015 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SPG11 SLC5A4 ADORA2A SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 3.03e-05 | 1157 | 118 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRG1 TCAF2 SPG11 SLC5A4 ADORA2A SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 3.17e-05 | 1374 | 118 | 21 | GO:0006811 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 3.23e-05 | 32 | 118 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | behavior | DPP4 ADGRB3 SPG11 ADORA2A CELSR1 TAS2R5 RPTOR MRGPRX1 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A TSPO DMD | 4.82e-05 | 891 | 118 | 16 | GO:0007610 |
| GeneOntologyBiologicalProcess | detection of external stimulus | 6.24e-05 | 173 | 118 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG1 TCAF2 SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 6.26e-05 | 1115 | 118 | 18 | GO:0034220 |
| GeneOntologyBiologicalProcess | transepithelial transport | 6.46e-05 | 38 | 118 | 4 | GO:0070633 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRG1 SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 6.69e-05 | 1017 | 118 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 6.71e-05 | 175 | 118 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 7.22e-05 | 922 | 118 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC5A4 SLC6A8 SLC9A4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD ABCC2 ATP2B1 KCNH5 | 9.28e-05 | 942 | 118 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | response to pain | 2.07e-04 | 51 | 118 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 2.58e-04 | 54 | 118 | 4 | GO:0008340 | |
| GeneOntologyBiologicalProcess | walking behavior | 3.88e-04 | 60 | 118 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 4.44e-04 | 238 | 118 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 4.80e-04 | 6 | 118 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 4.83e-04 | 27 | 118 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 5.54e-04 | 247 | 118 | 7 | GO:0009612 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | DPP4 CYP26B1 SRD5A3 HCAR3 SIDT2 RPTOR DHCR7 TSPO SCNN1B G6PC2 ABCC2 NR0B2 | 5.55e-04 | 684 | 118 | 12 | GO:0010817 |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 6.69e-04 | 7 | 118 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 6.69e-04 | 7 | 118 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 7.30e-04 | 31 | 118 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 7.92e-04 | 126 | 118 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 8.02e-04 | 32 | 118 | 3 | GO:0051156 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion | 8.88e-04 | 8 | 118 | 2 | GO:0061526 | |
| GeneOntologyBiologicalProcess | detection of stimulus | ABCA4 OR11G2 OR6C65 ADGRV1 TMEM87A TAS2R5 SCN1A PTPRQ SCN9A SCN10A TSPO TAS2R20 | 8.90e-04 | 722 | 118 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VN1R2 OR11G2 SIGMAR1 MCHR2 ADGRB2 ADGRB3 OR6C65 ADGRV1 ADGRL4 ADORA2A GPR161 HCAR3 CELSR1 IGF2R TAS2R5 GPR158 MRGPRX1 TAS2R20 | 9.55e-04 | 1395 | 118 | 18 | GO:0007186 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.02e-14 | 17 | 119 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 4.20e-14 | 29 | 119 | 9 | GO:0034706 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.04e-07 | 10 | 119 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.66e-07 | 25 | 119 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | cation channel complex | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 9.71e-07 | 235 | 119 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 1.08e-05 | 378 | 119 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | dynein complex | 1.39e-05 | 54 | 119 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRG1 SIGMAR1 ADGRB3 ADORA2A SLC6A8 GPR158 SCN1A SCN2A SCN8A SCN10A DMD ATP2B1 | 1.25e-04 | 583 | 119 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | node of Ranvier | 1.91e-04 | 20 | 119 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 2.00e-04 | 523 | 119 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRG1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCNN1B KCNH5 | 3.08e-04 | 550 | 119 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | apical plasma membrane | DPP4 SLC44A4 SLC6A8 SLC9A4 PTPRQ SCNN1B ABCG2 ABCC2 EMP2 ATP2B1 | 4.74e-04 | 487 | 119 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | plasma membrane protein complex | LILRB3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD TRAV23DV6 TRAV20 KCNH5 | 5.35e-04 | 785 | 119 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | axon initial segment | 5.90e-04 | 29 | 119 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | cell projection membrane | 8.12e-04 | 431 | 119 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.05e-03 | 277 | 119 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 1.13e-03 | 9 | 119 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.24e-03 | 82 | 119 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | lysosomal membrane | 1.32e-03 | 462 | 119 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.32e-03 | 462 | 119 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | main axon | 1.68e-03 | 89 | 119 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | axon | SIGMAR1 SPG11 ADORA2A MRGPRX1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DMD | 1.69e-03 | 891 | 119 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | apical part of cell | DPP4 SLC44A4 SLC6A8 SLC9A4 PTPRQ SCNN1B ABCG2 ABCC2 EMP2 ATP2B1 | 2.07e-03 | 592 | 119 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.24e-03 | 405 | 119 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.30e-03 | 161 | 119 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | vacuolar membrane | 2.48e-03 | 507 | 119 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | cell surface | DPP4 SLAMF9 ADGRV1 IGF2R MRC2 MRGPRX1 SCN5A SCNN1B ABCG2 TMEM102 DMD ABCC2 EMP2 KCNH5 | 4.29e-03 | 1111 | 119 | 14 | GO:0009986 |
| HumanPheno | Complex febrile seizure | 1.55e-07 | 16 | 44 | 5 | HP:0011172 | |
| HumanPheno | Focal hemiclonic seizure | 1.78e-06 | 25 | 44 | 5 | HP:0006813 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 2.67e-06 | 27 | 44 | 5 | HP:0031475 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 3.27e-06 | 13 | 44 | 4 | HP:0007058 | |
| HumanPheno | Childhood onset | TPP2 CCDC134 ABCA4 NUP85 SIGMAR1 SPG11 ADGRV1 STAT2 DNAH1 SCN1A SCN2A SCN3A PTPRQ SCN5A SCN8A SCNN1B ATM DMD ATP2B1 G6PC1 KCNH5 | 8.07e-06 | 938 | 44 | 21 | HP:0011463 |
| HumanPheno | Calcaneovalgus deformity | 8.80e-06 | 34 | 44 | 5 | HP:0001848 | |
| HumanPheno | Deformed tarsal bones | 1.02e-05 | 35 | 44 | 5 | HP:0008119 | |
| HumanPheno | Atypical absence status epilepticus | 1.06e-05 | 17 | 44 | 4 | HP:0011151 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.36e-05 | 18 | 44 | 4 | HP:0032860 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 2.12e-05 | 20 | 44 | 4 | HP:0032671 | |
| HumanPheno | Focal clonic seizure | 2.56e-05 | 42 | 44 | 5 | HP:0002266 | |
| HumanPheno | Talipes valgus | 2.60e-05 | 21 | 44 | 4 | HP:0004684 | |
| HumanPheno | Photosensitive myoclonic seizure | 3.27e-05 | 8 | 44 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 3.27e-05 | 8 | 44 | 3 | HP:0200048 | |
| HumanPheno | Tibial torsion | 3.81e-05 | 23 | 44 | 4 | HP:0100694 | |
| HumanPheno | Clonic seizure | 5.85e-05 | 81 | 44 | 6 | HP:0020221 | |
| HumanPheno | Limited knee extension | 7.36e-05 | 27 | 44 | 4 | HP:0003066 | |
| HumanPheno | Simple febrile seizure | 7.36e-05 | 27 | 44 | 4 | HP:0011171 | |
| HumanPheno | Focal aware seizure | 8.53e-05 | 28 | 44 | 4 | HP:0002349 | |
| HumanPheno | Focal impaired awareness seizure | 8.58e-05 | 126 | 44 | 7 | HP:0002384 | |
| HumanPheno | Limited neck range of motion | 9.46e-05 | 11 | 44 | 3 | HP:0000466 | |
| HumanPheno | Abnormality of the calcaneus | 1.14e-04 | 57 | 44 | 5 | HP:0008364 | |
| HumanPheno | Epilepsia partialis continua | 1.25e-04 | 12 | 44 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 1.25e-04 | 12 | 44 | 3 | HP:0032898 | |
| HumanPheno | Obsessive-compulsive trait | 1.65e-04 | 33 | 44 | 4 | HP:0008770 | |
| HumanPheno | Generalized clonic seizure | 1.86e-04 | 34 | 44 | 4 | HP:0011169 | |
| HumanPheno | Generalized tonic seizure | 1.99e-04 | 64 | 44 | 5 | HP:0010818 | |
| HumanPheno | Infection-related seizure | 2.08e-04 | 145 | 44 | 7 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 2.08e-04 | 145 | 44 | 7 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 2.08e-04 | 145 | 44 | 7 | HP:0002373 | |
| HumanPheno | Limitation of knee mobility | 2.09e-04 | 35 | 44 | 4 | HP:0010501 | |
| HumanPheno | Facial tics | 2.55e-04 | 15 | 44 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 2.55e-04 | 15 | 44 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 3.11e-04 | 16 | 44 | 3 | HP:0025101 | |
| HumanPheno | Status epilepticus | 3.25e-04 | 207 | 44 | 8 | HP:0002133 | |
| HumanPheno | Focal motor status epilepticus | 3.76e-04 | 17 | 44 | 3 | HP:0032663 | |
| HumanPheno | Visually-induced seizure | 4.48e-04 | 18 | 44 | 3 | HP:0020216 | |
| HumanPheno | Atypical absence seizure | 6.07e-04 | 46 | 44 | 4 | HP:0007270 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 7.17e-04 | 5 | 44 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 7.17e-04 | 5 | 44 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 7.17e-04 | 5 | 44 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 7.17e-04 | 5 | 44 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 7.17e-04 | 5 | 44 | 2 | HP:0032906 | |
| HumanPheno | Esophoria | 7.17e-04 | 5 | 44 | 2 | HP:0025312 | |
| HumanPheno | Allodynia | 7.17e-04 | 5 | 44 | 2 | HP:0012533 | |
| HumanPheno | Reflex seizure | 8.26e-04 | 22 | 44 | 3 | HP:0020207 | |
| HumanPheno | EEG with spike-wave complexes | 8.77e-04 | 88 | 44 | 5 | HP:0010850 | |
| HumanPheno | Focal tonic seizure | 9.44e-04 | 23 | 44 | 3 | HP:0011167 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 9.70e-04 | 52 | 44 | 4 | HP:0007334 | |
| Domain | Na_channel_asu | 6.22e-17 | 10 | 113 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 6.22e-17 | 10 | 113 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 6.22e-17 | 10 | 113 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 4.29e-14 | 6 | 113 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 4.29e-14 | 6 | 113 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | 1.80e-09 | 57 | 113 | 8 | IPR027359 | |
| Domain | - | 1.80e-09 | 57 | 113 | 8 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 3.00e-08 | 114 | 113 | 9 | IPR005821 | |
| Domain | Ion_trans | 3.00e-08 | 114 | 113 | 9 | PF00520 | |
| Domain | IQ_motif_EF-hand-BS | 7.17e-08 | 90 | 113 | 8 | IPR000048 | |
| Domain | IQ | 9.29e-08 | 93 | 113 | 8 | PS50096 | |
| Domain | GAIN_dom_N | 4.06e-07 | 11 | 113 | 4 | IPR032471 | |
| Domain | GAIN | 4.06e-07 | 11 | 113 | 4 | PF16489 | |
| Domain | IQ | 5.92e-07 | 81 | 113 | 7 | SM00015 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.21e-06 | 14 | 113 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.21e-06 | 14 | 113 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.21e-06 | 14 | 113 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.21e-06 | 14 | 113 | 4 | PF08393 | |
| Domain | MT | 1.21e-06 | 14 | 113 | 4 | PF12777 | |
| Domain | AAA_8 | 1.21e-06 | 14 | 113 | 4 | PF12780 | |
| Domain | DHC_fam | 1.65e-06 | 15 | 113 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.65e-06 | 15 | 113 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 1.65e-06 | 15 | 113 | 4 | PF03028 | |
| Domain | GPS | 1.79e-06 | 34 | 113 | 5 | SM00303 | |
| Domain | GPS | 2.08e-06 | 35 | 113 | 5 | PF01825 | |
| Domain | GPS | 2.41e-06 | 36 | 113 | 5 | PS50221 | |
| Domain | GPS | 2.77e-06 | 37 | 113 | 5 | IPR000203 | |
| Domain | IQ | 4.46e-06 | 71 | 113 | 6 | PF00612 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.26e-05 | 50 | 113 | 5 | PS00650 | |
| Domain | 7tm_2 | 1.26e-05 | 50 | 113 | 5 | PF00002 | |
| Domain | GPCR_2_secretin-like | 3.11e-05 | 60 | 113 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 3.11e-05 | 60 | 113 | 5 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.37e-05 | 61 | 113 | 5 | PS50261 | |
| Domain | ATPase_dyneun-rel_AAA | 7.48e-05 | 14 | 113 | 3 | IPR011704 | |
| Domain | AAA_5 | 7.48e-05 | 14 | 113 | 3 | PF07728 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 9.81e-05 | 40 | 113 | 4 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 9.81e-05 | 40 | 113 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 9.81e-05 | 40 | 113 | 4 | PS50227 | |
| Domain | GPCR_2_brain_angio_inhib | 1.08e-04 | 3 | 113 | 2 | IPR008077 | |
| Domain | Glucose-6-phosphatase | 1.08e-04 | 3 | 113 | 2 | IPR016275 | |
| Domain | AAA+_ATPase | 2.43e-04 | 144 | 113 | 6 | IPR003593 | |
| Domain | AAA | 2.43e-04 | 144 | 113 | 6 | SM00382 | |
| Domain | HormR | 4.50e-04 | 25 | 113 | 3 | SM00008 | |
| Domain | HRM | 6.33e-04 | 28 | 113 | 3 | PF02793 | |
| Domain | - | 2.71e-03 | 13 | 113 | 2 | 2.10.10.10 | |
| Domain | ABC_tran | 3.06e-03 | 48 | 113 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.06e-03 | 48 | 113 | 3 | PS50893 | |
| Domain | FN_type2_col-bd | 3.15e-03 | 14 | 113 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.15e-03 | 14 | 113 | 2 | PS51092 | |
| Domain | fn2 | 3.15e-03 | 14 | 113 | 2 | PF00040 | |
| Domain | FN2_1 | 3.15e-03 | 14 | 113 | 2 | PS00023 | |
| Domain | FN2 | 3.15e-03 | 14 | 113 | 2 | SM00059 | |
| Domain | ABC_TRANSPORTER_1 | 3.24e-03 | 49 | 113 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 3.44e-03 | 50 | 113 | 3 | IPR003439 | |
| Domain | - | 5.21e-03 | 18 | 113 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 5.21e-03 | 18 | 113 | 2 | SM00014 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.28e-11 | 31 | 89 | 8 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.70e-11 | 32 | 89 | 8 | M27455 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.25e-07 | 130 | 89 | 9 | M27454 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.66e-07 | 47 | 89 | 6 | M42524 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.81e-07 | 203 | 89 | 10 | M5485 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 9.23e-07 | 121 | 89 | 8 | M872 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRG1 ADORA2A RPTOR SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.90e-05 | 367 | 89 | 11 | M48346 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.33e-05 | 27 | 89 | 4 | M47755 | |
| Pathway | WP_DRAVET_SYNDROME | 2.71e-05 | 28 | 89 | 4 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.52e-04 | 43 | 89 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.81e-04 | 45 | 89 | 4 | M47670 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 2.19e-04 | 19 | 89 | 3 | M22005 | |
| Pubmed | 1.52e-19 | 9 | 121 | 8 | 16382098 | ||
| Pubmed | 2.15e-17 | 13 | 121 | 8 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.56e-15 | 6 | 121 | 6 | 23652591 | |
| Pubmed | 1.30e-13 | 9 | 121 | 6 | 15746173 | ||
| Pubmed | 4.69e-13 | 5 | 121 | 5 | 17724025 | ||
| Pubmed | 1.39e-10 | 4 | 121 | 4 | 17537961 | ||
| Pubmed | 1.39e-10 | 4 | 121 | 4 | 35031483 | ||
| Pubmed | 1.39e-10 | 4 | 121 | 4 | 29578003 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.64e-10 | 12 | 121 | 5 | 30175250 | |
| Pubmed | 6.95e-10 | 5 | 121 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 6.95e-10 | 5 | 121 | 4 | 22875929 | |
| Pubmed | 9.65e-09 | 8 | 121 | 4 | 9412493 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.27e-08 | 139 | 121 | 8 | 16985003 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 19284629 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 33895391 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23859570 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 12610651 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 19699781 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 18784617 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 17544618 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 32845893 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 20038812 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 28518218 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 25155934 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 17928448 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 14973256 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.03e-07 | 33 | 121 | 5 | 25713288 | |
| Pubmed | 1.36e-07 | 14 | 121 | 4 | 9373155 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 22260870 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 35801810 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.64e-07 | 4 | 121 | 3 | 8974318 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 1679748 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 39056782 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 24337656 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 16029194 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 23711479 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.42e-06 | 7 | 121 | 3 | 25818041 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.42e-06 | 7 | 121 | 3 | 24440715 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 25101983 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 3.09e-06 | 29 | 121 | 4 | 15203201 | |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 3.40e-06 | 9 | 121 | 3 | 17884088 | |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 3.40e-06 | 9 | 121 | 3 | 8854872 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TMEM87A SLC6A8 LSR IGF2R KIDINS220 LATS2 GPR158 ABCC2 ATP2B1 PTTG1IP VAT1 | 5.15e-06 | 569 | 121 | 11 | 30639242 |
| Pubmed | 5.48e-06 | 126 | 121 | 6 | 17897319 | ||
| Pubmed | TMEM214 TMEM87A SLC6A8 LSR TMEM161A IGF2R KIDINS220 DHCR7 ATP2B1 VAT1 | 5.80e-06 | 467 | 121 | 10 | 30194290 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 8169823 | ||
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 1.20e-05 | 2 | 121 | 2 | 24642470 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.20e-05 | 2 | 121 | 2 | 37901435 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.20e-05 | 2 | 121 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.20e-05 | 2 | 121 | 2 | 10827969 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24486332 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19694741 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.20e-05 | 2 | 121 | 2 | 11245985 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15047701 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.20e-05 | 2 | 121 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.20e-05 | 2 | 121 | 2 | 23016767 | |
| Pubmed | Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle. | 1.20e-05 | 2 | 121 | 2 | 11316257 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27153334 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12218411 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.20e-05 | 2 | 121 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.20e-05 | 2 | 121 | 2 | 25172946 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31439038 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19541926 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31943325 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11834499 | ||
| Pubmed | Sigma-1 receptors modulate neonatal Nav1.5 ion channels in breast cancer cell lines. | 1.20e-05 | 2 | 121 | 2 | 27160185 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.20e-05 | 2 | 121 | 2 | 15249644 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27690330 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11297555 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.20e-05 | 2 | 121 | 2 | 27174182 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18601978 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 1.20e-05 | 2 | 121 | 2 | 24998131 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.20e-05 | 2 | 121 | 2 | 23965409 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29873816 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.20e-05 | 2 | 121 | 2 | 19465131 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 1.20e-05 | 2 | 121 | 2 | 16847056 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24360055 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.20e-05 | 2 | 121 | 2 | 23735284 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32330377 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29649454 | ||
| Pubmed | The sigma-1 receptor binds to the Nav1.5 voltage-gated Na+ channel with 4-fold symmetry. | 1.20e-05 | 2 | 121 | 2 | 22952230 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26861708 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 1.20e-05 | 2 | 121 | 2 | 16111501 | |
| Pubmed | Metabolism, Transport and Drug-Drug Interactions of Silymarin. | 1.20e-05 | 2 | 121 | 2 | 31615114 | |
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 1.20e-05 | 2 | 121 | 2 | 37043976 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33096315 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 1.20e-05 | 2 | 121 | 2 | 30944319 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31292628 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19279232 | ||
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 1.20e-05 | 2 | 121 | 2 | 16054936 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 1.20e-05 | 2 | 121 | 2 | 17805013 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25793771 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34087576 | ||
| Interaction | SCN11A interactions | 1.46e-08 | 15 | 113 | 5 | int:SCN11A | |
| Interaction | SNTA1 interactions | 2.09e-06 | 105 | 113 | 7 | int:SNTA1 | |
| Interaction | SCN5A interactions | 6.45e-06 | 47 | 113 | 5 | int:SCN5A | |
| Interaction | LAMP2 interactions | GPR155 PTDSS1 SPG11 TMEM87A ADGRL4 SLC6A8 LSR SPPL2A IGF2R KIDINS220 RPTOR DHCR7 ATP2B1 VAT1 | 7.98e-06 | 609 | 113 | 14 | int:LAMP2 |
| Interaction | CACNA1D interactions | 9.13e-06 | 24 | 113 | 4 | int:CACNA1D | |
| Interaction | SCN4B interactions | 9.42e-06 | 8 | 113 | 3 | int:SCN4B | |
| Interaction | NEDD4L interactions | CYP26B1 XPO1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A SCN10A SCNN1B | 1.30e-05 | 320 | 113 | 10 | int:NEDD4L |
| Interaction | SCN1A interactions | 2.00e-05 | 29 | 113 | 4 | int:SCN1A | |
| Interaction | SCN10A interactions | 2.74e-05 | 11 | 113 | 3 | int:SCN10A | |
| Interaction | CACNA1B interactions | 5.37e-05 | 37 | 113 | 4 | int:CACNA1B | |
| Interaction | NEDD4 interactions | POLR2B XPO1 LATS2 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A SCN10A SCNN1B DMD | 5.51e-05 | 544 | 113 | 12 | int:NEDD4 |
| Interaction | NALCN interactions | 5.97e-05 | 14 | 113 | 3 | int:NALCN | |
| Interaction | CHP1 interactions | 1.04e-04 | 83 | 113 | 5 | int:CHP1 | |
| Cytoband | 2q24.3 | 8.15e-08 | 16 | 121 | 4 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.30e-05 | 127 | 121 | 5 | chr2q24 | |
| Cytoband | 15q15.1 | 2.66e-04 | 47 | 121 | 3 | 15q15.1 | |
| Cytoband | 2q24 | 3.73e-04 | 11 | 121 | 2 | 2q24 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.35e-19 | 9 | 75 | 8 | 1203 | |
| GeneFamily | Dyneins, axonemal | 6.24e-07 | 17 | 75 | 4 | 536 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 5.08e-05 | 3 | 75 | 2 | 912 | |
| GeneFamily | Glucose 6-phosphatases, catalytic | 5.08e-05 | 3 | 75 | 2 | 1074 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | GPR155 CYP26B1 ADGRB2 ADGRB3 PI15 DNAH7 CELSR1 MRC2 SCN1A DHCR7 DNAI4 DNAH6 CCDC17 | 3.54e-06 | 600 | 119 | 13 | M39055 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL | 5.73e-06 | 150 | 119 | 7 | M45769 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-08 | 184 | 120 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-08 | 184 | 120 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-08 | 184 | 120 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-07 | 145 | 120 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 2.46e-07 | 158 | 120 | 7 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.23e-07 | 189 | 120 | 7 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.83e-07 | 191 | 120 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.80e-07 | 194 | 120 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.20e-06 | 200 | 120 | 7 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-06 | 84 | 120 | 5 | f7ce09c6fb2795b7aecabce00cb9830b3c1a7d0e | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-06 | 84 | 120 | 5 | 5d5e519a6652029b9f5275c8e648bbb123fd07b9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.24e-06 | 84 | 120 | 5 | 2b477de422a9f6a8474cba05094577b88236a4f0 | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 4.81e-06 | 160 | 120 | 6 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.17e-06 | 162 | 120 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-06 | 173 | 120 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.86e-06 | 178 | 120 | 6 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.86e-06 | 178 | 120 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.29e-06 | 49 | 120 | 4 | 1002c6f5cfc09eb5cf882e0cf366d9ba8e456a57 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.29e-06 | 49 | 120 | 4 | d7fc93efa70b464da39192e4bd8b1e8ad19bbec1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-06 | 180 | 120 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 182 | 120 | 6 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 183 | 120 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 183 | 120 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 184 | 120 | 6 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 185 | 120 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 186 | 120 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.17e-05 | 187 | 120 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 187 | 120 | 6 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 188 | 120 | 6 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 188 | 120 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.25e-05 | 189 | 120 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.28e-05 | 190 | 120 | 6 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 191 | 120 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 191 | 120 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 191 | 120 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 192 | 120 | 6 | 25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 192 | 120 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 192 | 120 | 6 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 193 | 120 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-05 | 193 | 120 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.40e-05 | 193 | 120 | 6 | ddbd8944661ac3b0b5fe63471bdc24ba05598017 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.40e-05 | 193 | 120 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-05 | 193 | 120 | 6 | b93f6af5999ad207fef5edc2bd900c7c6342f626 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.40e-05 | 193 | 120 | 6 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 194 | 120 | 6 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-05 | 194 | 120 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.44e-05 | 194 | 120 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 194 | 120 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 195 | 120 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 195 | 120 | 6 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 196 | 120 | 6 | a4cc02ea41479d24044bd2ca6441f85d683c0ca9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 196 | 120 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 196 | 120 | 6 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 197 | 120 | 6 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.58e-05 | 197 | 120 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 198 | 120 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 198 | 120 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 198 | 120 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 198 | 120 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 198 | 120 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-05 | 199 | 120 | 6 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-05 | 199 | 120 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-05 | 199 | 120 | 6 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-05 | 199 | 120 | 6 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.67e-05 | 199 | 120 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.67e-05 | 199 | 120 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.67e-05 | 199 | 120 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.72e-05 | 200 | 120 | 6 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Biopsy_IPF-Epithelial-Differentiating_Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.72e-05 | 200 | 120 | 6 | 8dfce65e417d6dcacb871d93d1539cdf807002fe | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.72e-05 | 200 | 120 | 6 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.72e-05 | 200 | 120 | 6 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-05 | 200 | 120 | 6 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.72e-05 | 200 | 120 | 6 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-05 | 200 | 120 | 6 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 126 | 120 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-05 | 129 | 120 | 5 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.50e-05 | 137 | 120 | 5 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 141 | 120 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| Drug | APETx1, Anthopleura elegantissima | 1.88e-11 | 6 | 116 | 5 | ctd:C475726 | |
| Drug | Zonisamide | 1.81e-10 | 17 | 116 | 6 | DB00909 | |
| Drug | disopyramide | 1.60e-09 | 66 | 116 | 8 | CID000003114 | |
| Drug | pentobarbital | GABRG1 SIGMAR1 ADORA2A HCAR3 SCN3A SCN4A SCN9A SCN10A TSPO SCNN1B PTTG1IP KCNH5 | 1.71e-09 | 224 | 116 | 12 | CID000004737 |
| Drug | carbamazepine | XBP1 ADORA2A SCN2A SCN3A SCN4A SCN5A SCN9A SCN10A TSPO SCNN1B ABCG2 | 2.00e-09 | 179 | 116 | 11 | CID000002554 |
| Drug | pilsicainide | 3.37e-09 | 46 | 116 | 7 | CID000004820 | |
| Drug | AC1L1MOZ | 4.16e-09 | 27 | 116 | 6 | CID000031958 | |
| Drug | tocainide | 8.25e-09 | 30 | 116 | 6 | CID000038945 | |
| Drug | benzocaine | 3.14e-08 | 37 | 116 | 6 | CID000002337 | |
| Drug | diprafenone | 3.46e-08 | 19 | 116 | 5 | CID000071249 | |
| Drug | tetradotoxin | GABRG1 SIGMAR1 ADORA2A HCAR3 KIDINS220 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A TSPO SCNN1B | 3.95e-08 | 428 | 116 | 14 | CID000020382 |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 4.41e-08 | 8 | 116 | 4 | ctd:C489827 | |
| Drug | spiradoline | 1.22e-07 | 46 | 116 | 6 | CID000005620 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.29e-07 | 3 | 116 | 3 | ctd:C561228 | |
| Drug | lidocaine | 1.34e-07 | 160 | 116 | 9 | CID000003676 | |
| Drug | AC1NT1AF | 1.54e-07 | 25 | 116 | 5 | CID005322157 | |
| Drug | quindine | LILRB3 HCAR3 SCN3A SCN4A SCN5A SCN9A SCN10A SCNN1B ABCG2 KCNH5 | 1.85e-07 | 219 | 116 | 10 | CID000001065 |
| Drug | Pirmenolum | 1.90e-07 | 26 | 116 | 5 | CID000004853 | |
| Drug | verapamil | ABCA4 ADGRL4 HCAR3 RPTOR SCN3A SCN4A SCN5A SCN9A SCN10A SCNN1B ABCG2 ABCC2 ATP2B1 KCNH5 | 2.07e-07 | 490 | 116 | 14 | CID000002520 |
| Drug | PbTx-1 | 2.32e-07 | 27 | 116 | 5 | CID006437089 | |
| Drug | nefopam | 2.32e-07 | 27 | 116 | 5 | CID000004450 | |
| Drug | Sodium | 2.43e-07 | 84 | 116 | 7 | ctd:D012964 | |
| Drug | bepridil | 2.71e-07 | 126 | 116 | 8 | CID000002351 | |
| Drug | paraben | 2.82e-07 | 28 | 116 | 5 | CID000007175 | |
| Drug | strychnine HCl | 3.82e-07 | 181 | 116 | 9 | CID000005304 | |
| Drug | NSC7524 | 4.00e-07 | 182 | 116 | 9 | CID000005657 | |
| Drug | Lidocaine | 5.14e-07 | 4 | 116 | 3 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 5.14e-07 | 4 | 116 | 3 | ctd:C501880 | |
| Drug | NSC93767 | 5.68e-07 | 32 | 116 | 5 | CID000005658 | |
| Drug | propofol | 6.00e-07 | 191 | 116 | 9 | CID000004943 | |
| Drug | propafenone | 7.01e-07 | 98 | 116 | 7 | CID000004932 | |
| Drug | 5-hydroxypropafenone | 7.78e-07 | 34 | 116 | 5 | CID000107927 | |
| Drug | AC1L1W4O | 8.36e-07 | 15 | 116 | 4 | CID000036625 | |
| Drug | saxitoxin | 9.93e-07 | 65 | 116 | 6 | CID000037165 | |
| Drug | AC1L1CQC | 9.93e-07 | 65 | 116 | 6 | CID000002012 | |
| Drug | mexiletine | 1.09e-06 | 66 | 116 | 6 | CID000004178 | |
| Drug | dibucaine | 1.30e-06 | 68 | 116 | 6 | CID000003025 | |
| Drug | aprindine | 1.38e-06 | 38 | 116 | 5 | CID000002218 | |
| Drug | GBR 12909 | 1.42e-06 | 69 | 116 | 6 | CID000003455 | |
| Drug | amiodarone | 1.67e-06 | 160 | 116 | 8 | CID000002156 | |
| Drug | flecainide | 1.68e-06 | 71 | 116 | 6 | CID000003355 | |
| Drug | isoflurane | GABRG1 HCAR3 SCN3A SCN4A SCN9A SCN10A SCNN1B DMD ATP2B1 PTTG1IP | 1.69e-06 | 279 | 116 | 10 | CID000003763 |
| Drug | Tetrodotoxin | 1.80e-06 | 40 | 116 | 5 | ctd:D013779 | |
| Drug | S-ropivacaine | 1.80e-06 | 40 | 116 | 5 | CID000071273 | |
| Drug | moricizine | 1.85e-06 | 18 | 116 | 4 | CID000034632 | |
| Drug | Scorpion Venoms | 1.85e-06 | 18 | 116 | 4 | ctd:D012604 | |
| Drug | lamotrigine | 2.19e-06 | 116 | 116 | 7 | CID000003878 | |
| Drug | diphenhydramine | 2.32e-06 | 75 | 116 | 6 | CID000003100 | |
| Drug | fenpropathrin | 2.55e-06 | 6 | 116 | 3 | ctd:C044267 | |
| Drug | riluzole | 3.12e-06 | 174 | 116 | 8 | CID000005070 | |
| Drug | bupivacaine | 3.61e-06 | 125 | 116 | 7 | CID000002474 | |
| Drug | bupropion | 3.65e-06 | 81 | 116 | 6 | CID000000444 | |
| Drug | epicholesterol | ABCA4 GPX7 ADGRL4 HCAR3 LSR NAMPT FDPS DHCR7 TSPO G6PC2 ABCC2 ATP2B1 G6PC1 NR0B2 | 4.49e-06 | 636 | 116 | 14 | CID000000304 |
| Drug | indoxacarb | 5.02e-06 | 49 | 116 | 5 | CID000107720 | |
| Drug | glufosfamide | 7.45e-06 | 25 | 116 | 4 | CID000123628 | |
| Drug | Multicide | 7.45e-06 | 25 | 116 | 4 | CID000024365 | |
| Drug | ketamine | 8.05e-06 | 262 | 116 | 9 | CID000003821 | |
| Drug | AC1NSN3X | 8.16e-06 | 54 | 116 | 5 | CID005366189 | |
| Drug | Mexiletine | 1.06e-05 | 9 | 116 | 3 | ctd:D008801 | |
| Drug | triamterene | 1.16e-05 | 58 | 116 | 5 | CID000005546 | |
| Drug | encainide | 1.19e-05 | 28 | 116 | 4 | CID000048040 | |
| Drug | DPI 201-106 | 1.19e-05 | 28 | 116 | 4 | CID000005190 | |
| Drug | procaine | 1.36e-05 | 153 | 116 | 7 | CID000004914 | |
| Drug | oxcarbazepine | 1.58e-05 | 30 | 116 | 4 | CID000034312 | |
| Drug | zonisamide | 1.62e-05 | 62 | 116 | 5 | CID000005734 | |
| Drug | phenytoin | 1.68e-05 | 219 | 116 | 8 | CID000001775 | |
| Drug | pyraclofos | 1.73e-05 | 106 | 116 | 6 | CID000093460 | |
| Drug | dofetilide | 1.75e-05 | 63 | 116 | 5 | CID000071329 | |
| Drug | dihydrochloride | 1.75e-05 | 159 | 116 | 7 | CID000070978 | |
| Drug | RH-3421 | 2.06e-05 | 11 | 116 | 3 | CID000108039 | |
| Drug | chloroacetylajmaline | 2.06e-05 | 11 | 116 | 3 | CID000038681 | |
| Drug | resiniferatoxin | 2.20e-05 | 66 | 116 | 5 | CID000104826 | |
| Drug | orange dye | 2.57e-05 | 2 | 116 | 2 | CID000217048 | |
| Drug | Hexylcaine | 2.57e-05 | 2 | 116 | 2 | DB00473 | |
| Drug | Ranolazine | 2.57e-05 | 2 | 116 | 2 | DB00243 | |
| Drug | Phenytoin | 2.57e-05 | 2 | 116 | 2 | DB00252 | |
| Drug | Flecainide | 2.57e-05 | 2 | 116 | 2 | DB01195 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 2.57e-05 | 2 | 116 | 2 | ctd:C502265 | |
| Drug | gabapentin | 2.59e-05 | 169 | 116 | 7 | CID000003446 | |
| Drug | NSC15627 | 2.64e-05 | 34 | 116 | 4 | CID000002073 | |
| Drug | Ro 22-9194 | 2.74e-05 | 12 | 116 | 3 | CID000129209 | |
| Drug | T2755 | 3.13e-05 | 71 | 116 | 5 | CID000005514 | |
| Drug | Pyrethroids | 3.13e-05 | 71 | 116 | 5 | CID000005053 | |
| Drug | AC1LCJM3 | 3.55e-05 | 13 | 116 | 3 | CID000631640 | |
| Drug | CID6432355 | 3.55e-05 | 13 | 116 | 3 | CID006432355 | |
| Drug | sotalol | 3.59e-05 | 73 | 116 | 5 | CID000005253 | |
| Drug | fenfluramine | 3.61e-05 | 178 | 116 | 7 | CID000003337 | |
| Drug | sipatrigine | 3.71e-05 | 37 | 116 | 4 | CID000060803 | |
| Drug | 1, 3-diallylurea | 3.83e-05 | 74 | 116 | 5 | CID000074537 | |
| Drug | imide | 3.83e-05 | 74 | 116 | 5 | CID000443040 | |
| Drug | isofagomine | 4.09e-05 | 75 | 116 | 5 | CID000447607 | |
| Drug | lorcainide | 4.50e-05 | 14 | 116 | 3 | CID000042883 | |
| Drug | octylguanidine | 4.50e-05 | 14 | 116 | 3 | CID000030621 | |
| Drug | robinetin | 4.50e-05 | 14 | 116 | 3 | CID005281692 | |
| Drug | ranolazine | 4.58e-05 | 39 | 116 | 4 | CID000056959 | |
| Drug | procainamide | 5.47e-05 | 190 | 116 | 7 | CID000004913 | |
| Drug | trimethyloxonium | 5.61e-05 | 15 | 116 | 3 | CID000093245 | |
| Drug | nonanol | 5.61e-05 | 15 | 116 | 3 | CID000008914 | |
| Drug | QX-222 | 6.17e-05 | 42 | 116 | 4 | CID000005014 | |
| Drug | QX-314 | 6.28e-05 | 82 | 116 | 5 | CID000003925 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.86e-18 | 10 | 115 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.86e-18 | 10 | 115 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.03e-17 | 12 | 115 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.64e-08 | 163 | 115 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.72e-08 | 9 | 115 | 4 | C3502809 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.52e-06 | 22 | 115 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Ventricular Dysfunction | 3.18e-06 | 8 | 115 | 3 | C0242973 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.51e-05 | 2 | 115 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.60e-05 | 13 | 115 | 3 | C0751122 | |
| Disease | Colorectal Carcinoma | DNAH3 ABCA4 SETD4 SLC44A4 NAMPT SCNN1B ABCG2 DMD ABCC2 DSEL NLRP8 ZNF292 | 1.98e-05 | 702 | 115 | 12 | C0009402 |
| Disease | B Virus Infection | 4.51e-05 | 3 | 115 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 4.51e-05 | 3 | 115 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 4.51e-05 | 3 | 115 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 4.51e-05 | 3 | 115 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 4.51e-05 | 3 | 115 | 2 | C0014805 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 4.51e-05 | 3 | 115 | 2 | cv:C3468114 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 4.51e-05 | 3 | 115 | 2 | C1833661 | |
| Disease | status epilepticus (biomarker_via_orthology) | 4.62e-05 | 100 | 115 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Epilepsy | 6.97e-05 | 109 | 115 | 5 | C0014544 | |
| Disease | Brugada ECG Pattern | 8.99e-05 | 4 | 115 | 2 | C1721096 | |
| Disease | orotidine measurement | 8.99e-05 | 4 | 115 | 2 | EFO_0800630 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 8.99e-05 | 4 | 115 | 2 | C3468114 | |
| Disease | urate measurement, bone density | ADGRB3 ETS2 SLC44A4 FADS2B FBXL4 DNAH1 KIDINS220 LATS2 G6PC1 KCNH5 | 1.59e-04 | 619 | 115 | 10 | EFO_0003923, EFO_0004531 |
| Disease | renal overload-type gout | 2.24e-04 | 6 | 115 | 2 | EFO_0021525 | |
| Disease | Familial benign neonatal epilepsy | 2.24e-04 | 6 | 115 | 2 | C0220669 | |
| Disease | glycocholenate sulfate measurement | 2.24e-04 | 6 | 115 | 2 | EFO_0800276 | |
| Disease | presubiculum volume | 2.39e-04 | 31 | 115 | 3 | EFO_0009400 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder | 2.39e-04 | 31 | 115 | 3 | EFO_0003888, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | ABCA4 VPS39 ZSWIM5 ETS2 XBP1 TMEM161A FBXO8 SCNN1B ABCG2 ATM DMD G6PC1 NLRP8 | 2.89e-04 | 1074 | 115 | 13 | C0006142 |
| Disease | Seizure, Febrile, Simple | 3.12e-04 | 7 | 115 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 3.12e-04 | 7 | 115 | 2 | C0751057 | |
| Disease | electrocardiography, PR interval | 3.12e-04 | 7 | 115 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 3.12e-04 | 7 | 115 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 3.12e-04 | 7 | 115 | 2 | C0020075 | |
| Disease | metabolite measurement | 3.55e-04 | 560 | 115 | 9 | EFO_0004725 | |
| Disease | sex interaction measurement, Crohn's disease | 4.07e-04 | 37 | 115 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | Cataract | 4.07e-04 | 37 | 115 | 3 | C0086543 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 4.15e-04 | 8 | 115 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 4.15e-04 | 8 | 115 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 4.15e-04 | 8 | 115 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 4.15e-04 | 8 | 115 | 2 | C0751120 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 4.15e-04 | 8 | 115 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | Myoclonic Encephalopathy | 4.15e-04 | 8 | 115 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 4.15e-04 | 8 | 115 | 2 | C0393703 | |
| Disease | Neurodevelopmental Disorders | 4.89e-04 | 93 | 115 | 4 | C1535926 | |
| Disease | Inherited neuropathies | 5.13e-04 | 40 | 115 | 3 | C0598589 | |
| Disease | Tremor, Neonatal | 5.32e-04 | 9 | 115 | 2 | C0235843 | |
| Disease | Febrile Convulsions | 5.32e-04 | 9 | 115 | 2 | C0009952 | |
| Disease | Tremor, Perioral | 5.32e-04 | 9 | 115 | 2 | C0235078 | |
| Disease | Nerve Tremors | 5.32e-04 | 9 | 115 | 2 | C0235083 | |
| Disease | Tremor, Limb | 5.32e-04 | 9 | 115 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 5.32e-04 | 9 | 115 | 2 | C0235082 | |
| Disease | Senile Tremor | 5.32e-04 | 9 | 115 | 2 | C0149840 | |
| Disease | Pill Rolling Tremor | 5.32e-04 | 9 | 115 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 5.32e-04 | 9 | 115 | 2 | C0751565 | |
| Disease | Action Tremor | 5.32e-04 | 9 | 115 | 2 | C0234376 | |
| Disease | Passive Tremor | 5.32e-04 | 9 | 115 | 2 | C0234377 | |
| Disease | Static Tremor | 5.32e-04 | 9 | 115 | 2 | C0234378 | |
| Disease | Resting Tremor | 5.32e-04 | 9 | 115 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 5.32e-04 | 9 | 115 | 2 | C0234372 | |
| Disease | Fine Tremor | 5.32e-04 | 9 | 115 | 2 | C0234373 | |
| Disease | Coarse Tremor | 5.32e-04 | 9 | 115 | 2 | C0234374 | |
| Disease | Massive Tremor | 5.32e-04 | 9 | 115 | 2 | C0234375 | |
| Disease | Persistent Tremor | 5.32e-04 | 9 | 115 | 2 | C0234370 | |
| Disease | Continuous Tremor | 5.32e-04 | 9 | 115 | 2 | C0234371 | |
| Disease | Darkness Tremor | 5.32e-04 | 9 | 115 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 5.32e-04 | 9 | 115 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 5.32e-04 | 9 | 115 | 2 | C0040827 | |
| Disease | Myoclonic Epilepsy | 5.32e-04 | 9 | 115 | 2 | C0014550 | |
| Disease | supraventricular ectopy | 5.32e-04 | 9 | 115 | 2 | EFO_0009277 | |
| Disease | Bipolar Disorder | 5.75e-04 | 477 | 115 | 8 | C0005586 | |
| Disease | Epilepsy, Myoclonic, Infantile | 6.64e-04 | 10 | 115 | 2 | C0917800 | |
| Disease | Tremor | 8.09e-04 | 11 | 115 | 2 | C0040822 | |
| Disease | Myoclonic Astatic Epilepsy | 8.09e-04 | 11 | 115 | 2 | C0393702 | |
| Disease | Cardiomyopathy, Dilated | 8.78e-04 | 48 | 115 | 3 | C0007193 | |
| Disease | Prenatal Exposure Delayed Effects | 9.69e-04 | 12 | 115 | 2 | C0033054 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.11e-03 | 52 | 115 | 3 | C1168401 | |
| Disease | Brugada Syndrome 1 | 1.14e-03 | 13 | 115 | 2 | C4551804 | |
| Disease | nervous system disorder | 1.17e-03 | 53 | 115 | 3 | C0027765 | |
| Disease | T wave morphology measurement | 1.33e-03 | 14 | 115 | 2 | EFO_0008398 | |
| Disease | MMR-related febrile seizures | 1.53e-03 | 15 | 115 | 2 | EFO_0006519 | |
| Disease | P wave duration | 1.53e-03 | 15 | 115 | 2 | EFO_0005094 | |
| Disease | Seizures | 1.67e-03 | 218 | 115 | 5 | C0036572 | |
| Disease | Neuralgia, Supraorbital | 1.74e-03 | 16 | 115 | 2 | C0038870 | |
| Disease | Neuralgia | 1.74e-03 | 16 | 115 | 2 | C0027796 | |
| Disease | Romano-Ward Syndrome | 1.74e-03 | 16 | 115 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 1.74e-03 | 16 | 115 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.74e-03 | 16 | 115 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.74e-03 | 16 | 115 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.74e-03 | 16 | 115 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 1.74e-03 | 16 | 115 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.74e-03 | 16 | 115 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.74e-03 | 16 | 115 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.74e-03 | 16 | 115 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.74e-03 | 16 | 115 | 2 | C0393706 | |
| Disease | Intellectual Disability | 1.88e-03 | 447 | 115 | 7 | C3714756 | |
| Disease | Amyotrophic lateral sclerosis | 1.97e-03 | 17 | 115 | 2 | cv:C0002736 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.97e-03 | 17 | 115 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | breast carcinoma (is_marker_for) | 2.21e-03 | 66 | 115 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.21e-03 | 18 | 115 | 2 | HP_0002373 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCWLSTENNFIWSFI | 561 | Q9HBW9 | |
| FCWVLTEAWQSYLAV | 1011 | O60241 | |
| SLVCELQVWQGLAWA | 471 | Q96LX7 | |
| VSNAVIWCTWFLDSF | 691 | P78363 | |
| ILGNVLVCWAVWLNS | 21 | P29274 | |
| FFLASFCWVLTEAWQ | 951 | O60242 | |
| VNLTTIASWLSWLQY | 556 | Q9UNQ0 | |
| CLLWNQAAASWLSDS | 5856 | Q8WXG9 | |
| QISLDYWWCTNVVLR | 96 | Q3MIX3 | |
| WTLLWAACAQSLDLN | 306 | Q17RM4 | |
| QSLIWSWDQGFCQAL | 361 | Q17RM4 | |
| EWWLVNVACIRTGII | 126 | P0C7M7 | |
| DFCWLSLQDTLIWSF | 2601 | Q9NYQ6 | |
| WQRLTEEQCLFSAWL | 561 | P11532 | |
| EAWLDNFARCWDNLV | 641 | P11532 | |
| TIIFDNWIPLLWCAN | 171 | Q9UBM7 | |
| LAVLTFTLCSVVIWW | 421 | A4D256 | |
| FSCSELSIEQWLWSI | 1031 | P20020 | |
| NKVCNWLVISSWLAG | 136 | A6NJZ3 | |
| GLAFVLNCRTWWQVL | 701 | Q9ULH0 | |
| LNCRTWWQVLDSLLN | 706 | Q9ULH0 | |
| TQLCDWWSVGVILFE | 891 | Q9NRM7 | |
| WWQDLCSVFATNDKL | 691 | Q86W28 | |
| ANLSSCLWWLFNQEP | 671 | Q7Z3F1 | |
| VVFWFLIGWTSSVCQ | 536 | Q5T848 | |
| DSLQRAWTVGWCVEL | 146 | P14324 | |
| AWTVGWCVELLQAFF | 151 | P14324 | |
| LAVSQQLWQLRWAAT | 26 | Q9NR63 | |
| NVVWLLVATILSCGW | 26 | Q2LD37 | |
| CAFKTTWDWVILILT | 211 | Q8NCM2 | |
| ACNQQLCVEWAFSSW | 1601 | Q8N6G6 | |
| QILSAISNRALWWAV | 461 | Q8IWD5 | |
| IKECSIALSNWWFVA | 361 | Q9BW27 | |
| VCQWLLWATNEFSLV | 111 | P15036 | |
| CVWQDLANDELLWQG | 96 | Q9NRD0 | |
| WAQAQRICTWFQAEL | 846 | Q9UBG0 | |
| CDVTWATQERISLQW | 301 | P27487 | |
| RQWCVQKNSWFLSLF | 121 | Q92887 | |
| VTLLCQSWWQFDTFL | 341 | O75022 | |
| CEFNRSWLQIGIVSW | 251 | A1L453 | |
| VQWLQCCLESFWSLE | 146 | Q15466 | |
| LTLINCTSDFVWLKW | 1291 | Q9UMZ3 | |
| LQRYWVCFSLQDITW | 326 | A8MWK0 | |
| IISVLWNGFLLWCLT | 81 | Q9H8P0 | |
| WNGFLLWCLTQSLFL | 86 | Q9H8P0 | |
| TWWLVVTNVFFNQAL | 276 | Q9H8P0 | |
| LWSSIFSLNLLDAWN | 576 | Q3MJ16 | |
| ASCWNTSAELLNKSW | 6 | Q969V1 | |
| QEVLEEWLNCQRSWL | 1231 | Q9P2D7 | |
| PSLVNCCTIDWFNEW | 2731 | Q9P2D7 | |
| AALLFIATVDNAWWV | 16 | P54851 | |
| WCEISQQQWLELFSV | 156 | Q13315 | |
| WLTCQRNWLYLESIF | 1101 | Q9C0G6 | |
| PSLINCCTIDWFQSW | 2581 | Q8TD57 | |
| LQVYCAWSLLDNFEW | 411 | Q9H227 | |
| CILTVVLSWVSFWIN | 281 | Q8N1C3 | |
| QSRCTLVQWLNLSWT | 341 | Q9UKA2 | |
| WLGFWAVQLNVCLSR | 156 | P35575 | |
| ALVNCCTIDWFQSWP | 2491 | Q8WXX0 | |
| SFLWSVFWLIQISVC | 151 | Q9NQR9 | |
| WAAVAAGLWVLCTVI | 6 | K9M1U5 | |
| LSCSADWGVIIWQQE | 721 | Q5VTH9 | |
| REWIFGVVWCNFSAL | 91 | Q8N6U8 | |
| FWTLNWVLALGQCVL | 451 | Q53GD3 | |
| VAAAWLLLWAAACAQ | 6 | Q96SL4 | |
| TLLFAALVCWQWGIF | 56 | P51168 | |
| LWFIELLDVWSTCSQ | 811 | Q8IZU8 | |
| AVVFVWLLLSTWCTA | 71 | Q86X29 | |
| NLVVNCWVLGFIWFL | 181 | Q8NGC1 | |
| WLCAAAQVAALAAWL | 71 | O00198 | |
| LNWECVVSFLWNTEA | 906 | P11717 | |
| LKQTFLSVLWQVTCW | 286 | P59543 | |
| VTVLQIYFCDWQQAW | 316 | A8K8P3 | |
| ETSSWVNLVLWCVVL | 166 | Q7Z7N9 | |
| SFYLLTVLLACWENW | 306 | Q8NBJ9 | |
| QLSIAWASVLWFNLL | 461 | P52630 | |
| LSWSQETTKTWCVFN | 286 | B4DYI2 | |
| AWCWLDFLIVDVSII | 1096 | P35499 | |
| LAYLIWWTAACQLLA | 451 | Q9NX61 | |
| LCDWNVWTALETYLQ | 821 | A6NFQ2 | |
| LQWRQVSWITCWIAL | 16 | Q8N967 | |
| TSLCWNDLSWFQSIT | 201 | Q9NYQ3 | |
| NWTAAIISCLLWGIT | 141 | P49019 | |
| WCWLDFLIVDVSLVS | 1271 | Q14524 | |
| NAWCWLDFLIVDVSL | 1256 | Q15858 | |
| WNWAFICFTLAFCQI | 381 | Q6AI14 | |
| VLTQVVWLWLGTQSF | 21 | Q99720 | |
| LWQEACWIVISSYFD | 21 | P30876 | |
| IFSYSALLWAWCTVN | 191 | Q9NVD3 | |
| ALLWAWCTVNTRAVY | 196 | Q9NVD3 | |
| TALWYWCTNQVIVQR | 286 | Q9NY91 | |
| CYWLTNWIETILVQS | 141 | P43490 | |
| LQIQSLISCWAFWTT | 196 | P17861 | |
| SLSWCWNAEDVVAFV | 131 | Q8IZU2 | |
| TTLLWQAFWECVVVA | 481 | P48029 | |
| AWCWLDFLIVDVSLV | 1271 | Q9NY46 | |
| AWCQTSDFITVAWLI | 171 | Q96LB2 | |
| TGFLEQLKSCIVWSW | 6 | Q9NRC1 | |
| WVAICLGRIWQNFDS | 576 | Q8N122 | |
| RCEWQLENWQVALVT | 76 | Q8N434 | |
| TNAWCWLDFLIVDVS | 1281 | P35498 | |
| WNLLIRWGISFCNQT | 136 | Q9H6E4 | |
| RQCWVQGNAWISCIT | 96 | Q8NAA6 | |
| LNWALWWDQLTQESI | 851 | Q96JI7 | |
| VVLVAGTLCFAWWSE | 26 | Q8N0U2 | |
| LSIFWVLVSQASLWF | 81 | Q9NYW4 | |
| WKNLNTLCWAIGSIS | 491 | O14980 | |
| SCWLQQLQKWSDLDV | 436 | Q9P217 | |
| ECAFIVLWLQLGWLS | 6 | A0A0B4J274 | |
| WDLLICQELLNFFIW | 411 | A6NJ88 | |
| NAWCWLDFLIVNISL | 1216 | Q9Y5Y9 | |
| RWAWILQDILGIAFC | 311 | Q8TCT8 | |
| TNAWCWLDFLIVDVS | 1271 | Q99250 | |
| EAWPTLCSAQVAAWF | 256 | Q8N9M5 | |
| WTWLCLQDITVAFLD | 666 | Q6NUQ4 | |
| CAWELTLFWSKLQQR | 291 | O60281 | |
| EFCIARWWASLSDVN | 731 | P29144 | |
| TNAWCWLDFLIVAVS | 1261 | Q9UQD0 | |
| ARWGVCWVNFEALII | 86 | P53801 | |
| FCLWIPEDQLSWFAA | 36 | Q8N661 | |
| LWRWCGSEEVVAVLQ | 21 | Q96A28 | |
| LARTWWNQFSVTALQ | 301 | Q99536 | |
| NLAKSAEAWAATCIW | 96 | O43692 | |
| QESWTVWQLDCLACL | 1511 | Q70CQ2 | |
| GASFLVLWLQLCWVS | 6 | A0A075B6W5 | |
| LLPNFAECWWDQVIL | 206 | P48651 | |
| LAWLAFTTTLNYCVW | 141 | P30536 | |
| DTALCWWIFISLTQT | 371 | Q8NBN3 | |
| LQIDCLAAWEEWLLV | 16 | Q96JC1 | |
| WWLVNTAALIIACFP | 346 | Q8NFZ6 |